TY - JOUR T1 - Protecting healthcare workers during the COVID-19 pandemic: Australian results from the PPE-SAFE survey JF - medRxiv DO - 10.1101/2020.08.11.20172148 SP - 2020.08.11.20172148 AU - Mahesh Ramanan AU - Kevin B Laupland AU - Alexis Tabah Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/08/14/2020.08.11.20172148.abstract N2 - The COVID-19 pandemic has led to global shortages of personal protective equipment (PPE). Healthcare workers (HCW) have comprised a significant proportion of COVID-19 cases in many countries. The PPE-SAFE survey was conducted to study current practices, availability, shortages, training and confidence in PPE amongst intensive care HCWs around the world. Herein, we describe the results of the Australian respondents to the PPE-SAFE survey. 29% of respondents reported that at least one item of usually available PPE was missing, and 12% reported reuse of single-use items. Only 40% felt that the PPE available to them offered adequate protection. Fit-testing of respirators had never been performed for 47% of respondents, and 49% reported at least one adverse effect from the use of PPE.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNilAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Waiver of ethics was obtained from the Royal Brisbane and Women's Hospital Human Research Ethics Committee (LNR/2020/QRBW/63041).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available for sharing upon reasonable request to the Chief Investigator of PPE-SAFE, Dr. Alexis Tabah. ER -